European Union approves Daiichi Sankyo & AstraZeneca's Datroway to treat patients with metastatic hormone receptor ...
Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have …